Pediatric liver transplantation is a well-established and lifesaving intervention for children with end-stage liver disease, reflecting the collaborative efforts of medical professionals and the relentless pursuit of therapeutic advancements. Over the last several decades, graft and patient survival have shown marked improvements due to enhancements in medical management, surgical techniques, immunosuppression, and organ availability. The utilization of split-liver grafts and living-related donors has facilitated an expansion in the donor pool and allowed for decreased wait times to transplant. The outlook for pediatric liver transplantation shows ongoing advancements aimed at minimizing prolonged immunosuppression and embracing precision medicine. By integrating genetic and molecular profiling, there exists the potential for enhancing donor-recipient compatibility and tailoring treatment plans to individual needs. Future developments will continue to focus on long-term outcomes with prevention of immunosuppression-related complications, transition of care, and health-related quality of life.

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Advancements in Pediatric Liver Transplantation: Innovations and Future Directions

  • Jennifer Vittorio,
  • Adam Griesemer

摘要

Pediatric liver transplantation is a well-established and lifesaving intervention for children with end-stage liver disease, reflecting the collaborative efforts of medical professionals and the relentless pursuit of therapeutic advancements. Over the last several decades, graft and patient survival have shown marked improvements due to enhancements in medical management, surgical techniques, immunosuppression, and organ availability. The utilization of split-liver grafts and living-related donors has facilitated an expansion in the donor pool and allowed for decreased wait times to transplant. The outlook for pediatric liver transplantation shows ongoing advancements aimed at minimizing prolonged immunosuppression and embracing precision medicine. By integrating genetic and molecular profiling, there exists the potential for enhancing donor-recipient compatibility and tailoring treatment plans to individual needs. Future developments will continue to focus on long-term outcomes with prevention of immunosuppression-related complications, transition of care, and health-related quality of life.